Karina Makarenko

Karina Makarenko

Auto-generated profile, based on publicly available information

Karina Makarenko

Department of Woman, Mother and Neonate, Buzzi Hospital, Biomedical and Clinical Sciences School of Medicine, University of Milan, 20122 Milan, Italy

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 June 2013 in BioMed Research International
Verified
Journal Article
Open access
PDF file
VFVassilios Fanos
Vassilios Fanos
Luigi AtzoriLuigi Atzori
Luigi Atzori
KMKarina Makarenko
Karina Makarenko
GMGian Benedetto Melis
Gian Benedetto Melis
FMFerrazzi Enrico Maria
Ferrazzi Enrico Maria
Metabolomics in maternal-fetal medicine is still an “embryonic” science. However, there is already an increasing interest in metabolome of normal and complicated pregnancies, and neonatal outcomes. Tissues used for metabolomics interrogations of pregnant women, fetuses and newborns are amniotic fluid, blood, plasma, cord blood, placenta, urine, and vaginal secretions. All published papers highlight the strong correlation between biomarkers found in these tissues and fetal malformations, preterm delivery, premature rupture of membranes, gestational diabetes mellitus, preeclampsia, neonatal asphyxia, and hypoxic-ischemic encephalopathy. The aim of this review is to summarize and comment on original data available in relevant published works in order to emphasize the clinical potential of metabolomics in obstetrics in the immediate future.